Aarti Drugs Ltd.
AARTIDRUGS Share PricePharmaceuticals & Drugs
₹463.45
-5.7 (-1.2%)
As on November 14, 2025
Exchange Scrips: BSE524348NSEAARTIDRUGSISININE767A01016
Market Cap ₹ 4,244 Cr
P/E Ratio 25.15
Dividend Yield 0.02 %
Performance
Market performance
Open469
High469.4
Volumes1,48,104
Prev463.45
Low461.15
As on2025-11-14
Historical performance
1 Year High564.05
3 Year High645.75
5 Year High841.8
1 Year Low312
3 Year Low312
5 Year Low312
Fundamentals
Company Valuation
Market Cap (₹Cr)
4,244
Face Value (₹)
10
P/E Ratio
25.15
Dividend Yield
0.02 %
Investment Returns
1 Year
-1.3%
3 Years
0.1%
5 Years
-35.3%
10 Years
251.7%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 480.6 | Bearish |
| 10-DMA | 488.15 | Bearish |
| 20-DMA | 496.23 | Bearish |
| 50-DMA | 499.46 | Bearish |
| 100-DMA | 495 | Bearish |
| 200-DMA | 446.29 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 39 | 41 | 41 | 41 | 41 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 39 | 41 | 41 | 41 | 41 |
| Public Investors | 152213 | 160219 | 169720 | 175965 | 190240 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 25.15.
- 3Y Stock Price CAGR of the stock is 0.4.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹3066 Million.
- The company generated revenue of ₹23870 Million in the previous financial year.
Aarti Drugs Ltd.
463.45-5.7 (-1.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1006624.7
No. of Shares: 2172 (Approx)
Performance:0.7%
P/L: ₹6624.7
Top Gainers
Top Losers
| Symbol | Change% |
|---|---|
| TOLINS | 168.46(-10%) |
| FISCHER | 58.75(-10%) |
| WEALTH | 1051.8(-10%) |
| ATL | 31.49(-9%) |
| MASTERTR | 104.98(-8%) |
| THOMASCOTT | 418.7(-8%) |
| MALLCOM | 1270.2(-8%) |
| LAXMIINDIA | 137.12(-7%) |
Peer Comparison
Get Your Portfolio Reviewed
